Yokoyama et al reported that NGR-endostatin showed increased binding to endothelial cells and had higher tumor localization than the native protein, and increased binding of endostatin also coincided with improved antiangiogenic properties of endostatin [11]. This evidence concerns the gene RTN4R and neoplasm.